T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Zions Bancorporation
ZION
$10.4B
| $45.2M | 0.01% |
1,674,361
+13,360
| +0.8% | +$350K |
|
|
UBA
877
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $45.2M | 0.01% |
1,958,570
+28,790
| +1% | +$661K |
|
|
AEGN
878
DELISTED
Aegion Corp
AEGN
| $44.9M | 0.01% |
2,485,150
-45,660
| -2% | -$781K |
|
|
EQY
879
DELISTED
Equity One
EQY
| $44.9M | 0.01% |
1,680,496
+12,860
| +0.8% | +$346K |
|
880
Cavco Industries
CVCO
$4.59B
| $44.8M | 0.01% |
597,000
-149,277
| -20% | -$11M |
|
881
Ethan Allen Interiors
ETD
$578M
| $44.4M | 0.01% |
1,606,380
+125,970
| +9% | +$3.59M |
|
|
COL
882
DELISTED
Rockwell Collins
COL
| $44.2M | 0.01% |
457,879
+15,436
| +3% | +$1.38M |
|
|
ELRC
883
DELISTED
ELECTRO RENT CORP
ELRC
| $43.5M | 0.01% |
3,834,780
+9,500
| +0.2% | +$117K |
|
|
NATL
884
DELISTED
National Interstate Corporation
NATL
| $43.5M | 0.01% |
1,548,180
-4,000
| -0.3% | -$109K |
|
|
CSS
885
DELISTED
CSS Industries, Inc.
CSS
| $43.3M | 0.01% |
1,435,650
-13,860
| -1% | -$397K |
|
|
SASR
886
DELISTED
Sandy Spring Bancorp Inc
SASR
| $43.2M | 0.01% |
1,646,030
+168,400
| +11% | +$4.31M |
|
887
Edwards Lifesciences
EW
$53.2B
| $43.2M | 0.01% |
1,818,210
+67,200
| +4% | +$1.51M |
|
888
Ventas
VTR
$46.3B
| $43.1M | 0.01% |
517,322
+82,434
| +19% | +$7.1M |
|
889
Kforce
KFRC
$1.04B
| $43M | 0.01% |
1,925,666
-358,399
| -16% | -$8.33M |
|
890
Piper Sandler
PIPR
$5.39B
| $42.3M | 0.01% |
3,222,580
-126,300
| -4% | -$1.72M |
|
891
Ironwood Pharmaceuticals
IRWD
$687M
| $42.1M | 0.01% |
3,140,516
+1,981,596
| +171% | +$26M |
|
|
LO
892
DELISTED
LORILLARD INC COM STK
LO
| $42M | 0.01% |
642,500
-1,900
| -0.3% | -$126K |
|
893
Fomento Económico Mexicano
FMX
$39.8B
| $41.6M | 0.01% |
444,865
-87,635
| -16% | -$7.82M |
|
|
INVN
894
DELISTED
Invensense Inc
INVN
| $41.6M | 0.01% |
2,732,840
+369,047
| +16% | +$5.81M |
|
895
Boston Scientific
BSX
$74.4B
| $41.2M | 0.01% |
2,321,493
+92,030
| +4% | +$1.45M |
|
896
Coca-Cola Consolidated
COKE
$12.6B
| $41.2M | 0.01% |
3,640,900
-447,800
| -11% | -$4.54M |
|
897
ONE Gas
OGS
$5.09B
| $41.2M | 0.01% |
951,980
+930,280
| +4,287% | +$39.8M |
|
898
WIX.com
WIX
$3.11B
| $41.1M | 0.01% |
2,146,561
+428,618
| +25% | +$8.13M |
|
|
LLTC
899
DELISTED
Linear Technology Corp
LLTC
| $41M | 0.01% |
875,690
+10,390
| +1% | +$486K |
|
|
ADPT
900
DELISTED
Adeptus Health Inc
ADPT
| $40.7M | 0.01% |
811,370
+3,890
| +0.5% | +$154K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.